TSCO
53
4
AMGN
30
7
AVB
60
5
JBHT
39
11
AES
56
7
MO
53
-6
WMT
70
2
AMP
61
-3
PPG
57
4
HSY
38
-3
CMS
57
-11
SCHW
73
2
AXP
78
7
ETN
79
7
BBY
58
6
BAX
54
4
ACN
59
7
BMY
46
3
PYPL
83
6
CTSH
63
4
TSCO
53
4
AMGN
30
7
AVB
60
5
JBHT
39
11
AES
56
7
MO
53
-6
WMT
70
2
AMP
61
-3
PPG
57
4
HSY
38
-3
CMS
57
-11
SCHW
73
2
AXP
78
7
ETN
79
7
BBY
58
6
BAX
54
4
ACN
59
7
BMY
46
3
PYPL
83
6
CTSH
63
4
Financhill
Back

AnaptysBio 10K Form

Sell
26

ANAB
AnaptysBio

Last Price:
$20.53
Seasonality Move:
-5.74%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-02 10Q ANAB/AnaptysBio Quarterly
2023-08-07 10Q ANAB/AnaptysBio Quarterly
2023-05-11 10Q ANAB/AnaptysBio Quarterly
2022-11-08 10Q ANAB/AnaptysBio Quarterly
2022-08-08 10Q ANAB/AnaptysBio Quarterly
2022-05-04 10Q ANAB/AnaptysBio Quarterly

Receive ANAB News And Ratings

See the #1 stock for the next 7 days that we like better than ANAB

ANAB Financial Statistics

Sales & Book Value

Annual Sales: $91.3M
Cash Flow: $-10.7M
Price / Cash Flow: 0
Annual Sales: $1.12
Price / Book: 17.3

Profitability

EPS (TTM): -4.85000
Net Income (TTM): $-140.6M
Gross Margin: $5.5M
Return on Equity: -284.76%
Return on Assets: -31.5%

AnaptysBio Earnings Forecast

Key AnaptysBio Financial Ratios

  • The Gross Profit Margin over the past 1 years for ANAB is 99.95%.
  • The Selling, General & Administrative Expenses for ANAB have been equal to 46.44% of Gross Profit Margin.
  • The Research & Development expenses have been 179.49% of Revenue.
  • The Net Earning history of ANAB is -159.10% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 4 years.

AnaptysBio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ANAB
CUSIP: 032724
Website: anaptysbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 8.25
Quick Ratio: 8.13

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ANAB Technical Analysis vs Fundamental Analysis

Sell
26
AnaptysBio (ANAB) is a Sell

Is AnaptysBio a Buy or a Sell?

  • AnaptysBio stock is rated a Sell
    The current AnaptysBio [ANAB] share price is $20.52. The Score for ANAB is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.